Rituximab (Intravenous Route)

Mayo Clinic Health Manager

Get free personalized health guidance for you and your family.

Get Started

Free

E-Newsletter

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Rituximab (Intravenous Route)

Drug Information provided by: Micromedex

US Brand Names

  • Rituxan

Description

Rituximab injection is a monoclonal antibody. It is used to treat a type of cancer called non-Hodgkin's lymphoma. It can be used alone or with other cancer medicines (chemotherapy).

Rituximab may also be used in combination with methotrexate to reduce the signs and symptoms of rheumatoid arthritis and help keep joint damage from getting worse after at least one other medicine (e.g., adalimumab, etanercept, infliximab) has been used and did not work well.

This medicine is to be administered only by or under the immediate supervision of your doctor.

Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, rituximab is used in certain patients with the following medical conditions:

  • Chronic lymphocytic leukemia (cancer of the blood and lymph system).
  • Immune or idiopathic thrombocytopenic purpura (ITP) (a blood disease).
  • Waldenstrom's macroglobulinemia (cancer of the blood).

This product is available in the following dosage forms:

  • Solution
Before Using

DR601789

Portions of this document last updated:

Dec. 1, 2009

Source: Drug Information provided by: Micromedex

Copyright © 2010 Thomson Healthcare Inc. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.


Text Size: smaller largerlarger